Arriving in the landscape of excess body fat management, retatrutide presents a unique approach. Different from many current medications, retatrutide operates as a double agonist, simultaneously affecting both GLP peptide-1 (GLP-1) and glucose-responsive insulinotropic substance (GIP) receptors. This simultaneous activation fosters multiple benefic